Skip to main content
OpenTrials

Clinical trial condition

Plaque Psoriasis

Explore clinical trials studying Plaque Psoriasis. Study availability and eligibility vary by location and protocol.

295 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Plaque Psoriasis trial results

Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

NCT07116967

Conditions
Plaque Psoriasis
Locations
  • Local Institution - 0088 Birmingham, Alabama, United States
  • Medical Dermatology Specialists - Phoenix Phoenix, Arizona, United States
  • Saguaro Dermatology - Phoenix Phoenix, Arizona, United States
  • Omni Dermatology Phoenix, Arizona, United States
View all 394 locations
View Trial Details
Recruiting

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

NCT07250802

Conditions
Plaque Psoriasis
Locations
  • Exalt Clinical Research Chula Vista, California, United States
  • First OC Dermatology Research Inc. Fountain Valley, California, United States
  • Direct Helpers Medical Center Hialeah, Florida, United States
  • Arlington Dermatology Rolling Meadows, Illinois, United States
View all 40 locations
View Trial Details
Recruiting

Modifying PEST for Psoriatic Arthritis Screening

NCT06382051

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +12 more
Locations
  • Novartis Investigative Site Calgary, Alberta, Canada
  • Novartis Investigative Site Edmonton, Alberta, Canada
  • Novartis Investigative Site Edmonton, Alberta, Canada
  • Novartis Investigative Site Kelowna, British Columbia, Canada
View all 30 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

NCT06979453

Conditions
Exanthema, Pathological Conditions, Signs and Symptoms, Plaque Psoriasis, +7 more
Locations
  • Local Institution - 0261 Birmingham, Alabama, United States
  • Local Institution - 0041 Birmingham, Alabama, United States
  • Local Institution - 0053 Phoenix, Arizona, United States
  • Local Institution - 0025 Fountain Valley, California, United States
View all 129 locations
View Trial Details
Recruiting

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT07474792

Conditions
Plaque Psoriasis
Locations
  • Oruka Therapeutics Investigative Site Birmingham, Alabama, United States
  • Oruka Therapeutics Investigative Site Fountain Valley, California, United States
  • Oruka Therapeutics Investigative Site Los Angeles, California, United States
  • Oruka Therapeutics Investigative Site San Diego, California, United States
View all 34 locations
View Trial Details
Recruiting

Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis

NCT07039110

Conditions
Plaque Psoriasis
Locations
  • Dermatology Research Institute - Blackfoot Trail /ID# 276722 Calgary, Alberta, Canada
  • Rejuvenation Dermatology - Edmonton Downtown /ID# 276688 Edmonton, Alberta, Canada
  • Winnipeg Clinic /ID# 276751 Winnipeg, Manitoba, Canada
  • Wiseman Dermatology Research /ID# 276847 Winnipeg, Manitoba, Canada
View all 81 locations
View Trial Details
Recruiting

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

NCT07449702

Conditions
Plaque Psoriasis
Locations
  • Oruka Therapeutics Investigative Site Fountain Valley, California, United States
  • Oruka Therapeutics Investigative Site Los Angeles, California, United States
  • Oruka Therapeutics Investigative Site San Diego, California, United States
  • Oruka Therapeutics Investigative Site Santa Ana, California, United States
View all 24 locations
View Trial Details
Recruiting

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT07290569

Conditions
Plaque Psoriasis
Locations
  • Oruka Therapeutics Investigative Site Phoenix, Arizona, United States
  • Oruka Therapeutics Investigative Site North Little Rock, Arkansas, United States
  • Oruka Therapeutics Investigative Site Los Angeles, California, United States
  • Oruka Therapeutics Investigative Site Los Angeles, California, United States
View all 36 locations
View Trial Details
Recruiting

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis

NCT04772079

Conditions
Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Instituto de Neumonologia Y Dermatologia Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Psoriahue Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • CONEXA Investigacion Clinica S.A. Buenos Aires, Argentina
  • Centro de Investigaciones Metabólicas (CINME) Buenos Aires, Argentina
View all 63 locations
View Trial Details

Related conditions